Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Leard-ngam Remedy vs Mefenamic Acid for Primary Dysmenorrhea
TCTR20230516010Phase 2Completed
- Sponsor
- Chulabhorn International College of Medicine
- Start
- Oct 2022
- Countries
- 1
01
Overview
Phase 2 trial in primary dysmenorrhea (PD) (2 arms), sponsored by Chulabhorn International College of Medicine. Started Oct 2022; status: completed.
02
Conditions
primary dysmenorrhea (PD)
Beyond the preview
Go deeper on TCTR20230516010.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on TCTR20230516010.